How much funding has Human Longevity raised?

Human Longevity has raised $369.8M in total funding, most recently a Series B round.

When was Human Longevity founded?

Human Longevity was founded in 2013.

Where is Human Longevity headquartered?

Human Longevity is headquartered in San Diego, California, United States.

What industry is Human Longevity in?

Human Longevity operates in Biotech.

How many employees does Human Longevity have?

Human Longevity has 51-200 employees.

Human Longevity

Q: Who are Human Longevity's investors?

Human Longevity's investors include Illumina Ventures, GE Ventures, Celgene Corporation.

Transforming Longevity Through Personalized Medicine

San Diego, United States · Founded 2013 · $369.8M raised

Biotech

Headquarters: San Diego, California
Employees: 51–200
Founded: 2013
Business Model: B2C

Website: humanlongevity.com
Total Funding: $369.8M
Last Round: $39.8M Series BAug 2024
Rounds: 4

About

Human Longevity is a precision medicine company that integrates genomics, whole-body MRI, microbiome analysis, and clinical data to detect life-threatening conditions before symptoms appear. Founded in 2013 by J. Craig Venter, the company operates longevity clinics in San Diego, San Francisco, and Beijing offering comprehensive executive health assessments. It has published 20+ peer-reviewed papers and is ranked among the top 50 biomedical companies globally by Nature Index.

Summary

Human Longevity is a Biotech company based in San Diego, United States, founded in 2013. It has raised $369.8M in total across 4 rounds, most recently a $39.8M Series B round in Aug 2024. Investors include Illumina Ventures, GE Ventures and Celgene Corporation.

LinkedIn X (Twitter)GitHub